Search details
1.
Palbociclib with Fulvestrant or Letrozole in Endocrine-Sensitive Patients with HR-Positive/HER2-Negative Advanced Breast Cancer: A Detailed Safety Analysis of the Randomized PARSIFAL Trial.
Oncologist
; 28(1): 23-32, 2023 01 18.
Article
in English
| MEDLINE | ID: mdl-36239405
2.
Prevalence of MLH1 constitutional epimutations as a cause of Lynch syndrome in unselected versus selected consecutive series of patients with colorectal cancer.
J Med Genet
; 52(7): 498-502, 2015 Jul.
Article
in English
| MEDLINE | ID: mdl-25908759
3.
Preventing alpelisib-related hyperglycaemia in HR+/HER2-/PIK3CA-mutated advanced breast cancer using metformin (METALLICA): a multicentre, open-label, single-arm, phase 2 trial.
EClinicalMedicine
; 71: 102520, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38638399
4.
Early increase in tamoxifen dose in CYP2D6 poor metaboliser breast cancer patients and survival: A propensity score matching analysis.
Breast
; 69: 342-348, 2023 Jun.
Article
in English
| MEDLINE | ID: mdl-37011481
5.
Machine Learning Models and Multiparametric Magnetic Resonance Imaging for the Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer.
Cancers (Basel)
; 14(14)2022 Jul 19.
Article
in English
| MEDLINE | ID: mdl-35884572
6.
Fulvestrant-Palbociclib vs Letrozole-Palbociclib as Initial Therapy for Endocrine-Sensitive, Hormone Receptor-Positive, ERBB2-Negative Advanced Breast Cancer: A Randomized Clinical Trial.
JAMA Oncol
; 7(12): 1791-1799, 2021 12 01.
Article
in English
| MEDLINE | ID: mdl-34617955
7.
CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and BRCA2 carriers.
Breast Cancer Res Treat
; 119(1): 87-93, 2010 Jan.
Article
in English
| MEDLINE | ID: mdl-19214744
8.
Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers.
Breast Cancer Res Treat
; 119(1): 221-32, 2010 Jan.
Article
in English
| MEDLINE | ID: mdl-19370414
9.
Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01).
J Clin Oncol
; 38(3): 203-213, 2020 01 20.
Article
in English
| MEDLINE | ID: mdl-31804894
10.
Dynamic clonal remodelling in breast cancer metastases is associated with subtype conversion.
Eur J Cancer
; 120: 54-64, 2019 10.
Article
in English
| MEDLINE | ID: mdl-31491604
11.
Broad consensus on the optimal sequence for the systemic treatment of metastatic breast cancer: results from a survey of Spanish medical oncologists.
J Drug Assess
; 8(1): 62-69, 2019.
Article
in English
| MEDLINE | ID: mdl-31069129
12.
[BRCA1 and BRCA2 mutations in families studied in the program of genetic counselling in cancer of the Valencian community (Spain)]. / Mutaciones de BRCA1 y BRCA2 en familias estudiadas en el Programa de Consejo Genético en el Cáncer de la Comunidad Valenciana.
Med Clin (Barc)
; 130(4): 121-6, 2008 Feb 09.
Article
in Spanish
| MEDLINE | ID: mdl-18279628
13.
Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer.
Cancer Res
; 77(9): 2213-2221, 2017 05 01.
Article
in English
| MEDLINE | ID: mdl-28249905
14.
Broad BRCA1 and BRCA2 mutational spectrum and high incidence of recurrent and novel mutations in the eastern Spain population.
Breast Cancer Res Treat
; 121(1): 257-60, 2010 May.
Article
in English
| MEDLINE | ID: mdl-20033483
15.
Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study.
J Clin Oncol
; 33(32): 3788-95, 2015 Nov 10.
Article
in English
| MEDLINE | ID: mdl-26416999
16.
Adjusting the dose of tamoxifen in patients with early breast cancer and CYP2D6 poor metabolizer phenotype.
Breast
; 23(4): 400-6, 2014 Aug.
Article
in English
| MEDLINE | ID: mdl-24685597
17.
Novel and recurrent BRCA1/BRCA2 mutations in early onset and familial breast and ovarian cancer detected in the Program of Genetic Counseling in Cancer of Valencian Community (eastern Spain). Relationship of family phenotypes with mutation prevalence.
Fam Cancer
; 12(4): 767-77, 2013 Dec.
Article
in English
| MEDLINE | ID: mdl-23479189
18.
Cáncer de mama metastásico: es el momento del cirujano / Metastatic breast cancer: Now is the time for surgeons
Rev. senol. patol. mamar. (Ed. impr.)
; 34(1): 62-63, ene. -mar. 2021.
Article
in Spanish
| IBECS (Spain) | ID: ibc-230557
19.
Relationship of BRCA1 and BRCA2 mutations with cancer burden in the family and tumor incidence.
Fam Cancer
; 9(3): 291-5, 2010 Sep.
Article
in English
| MEDLINE | ID: mdl-20711702
20.
Identification of a novel BRCA1 large genomic rearrangement in a Spanish breast/ovarian cancer family.
Breast Cancer Res Treat
; 112(1): 63-7, 2008 Nov.
Article
in English
| MEDLINE | ID: mdl-18060491